The immunoregulatory role of CD1d-restricted iNKT cells in the transactivation of innate and adaptive immune responses has been well demonstrated [7,23], and several studies have exploited iNKT cells for therapeutic cancer vaccination [24,25]. This evidence concerns the gene CD1D and cancer.